SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-15-000100
Filing Date
2015-01-06
Accepted
2015-01-06 14:44:02
Documents
21
Period of Report
2015-01-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_010615.htm 8-K 24060
2 EXHIBIT 99.1 exh_991.htm EX-99.1 17888
3 exh991_01.jpg GRAPHIC 56526
4 exh991_02.jpg GRAPHIC 114182
5 exh991_03.jpg GRAPHIC 95835
6 exh991_04.jpg GRAPHIC 119693
7 exh991_05.jpg GRAPHIC 116870
8 exh991_06.jpg GRAPHIC 110803
9 exh991_07.jpg GRAPHIC 103720
10 exh991_08.jpg GRAPHIC 105282
11 exh991_09.jpg GRAPHIC 118350
12 exh991_10.jpg GRAPHIC 119125
13 exh991_11.jpg GRAPHIC 109893
14 exh991_12.jpg GRAPHIC 96460
15 exh991_13.jpg GRAPHIC 84465
16 exh991_14.jpg GRAPHIC 131945
17 exh991_15.jpg GRAPHIC 144553
18 exh991_16.jpg GRAPHIC 102551
19 exh991_17.jpg GRAPHIC 106302
20 exh991_18.jpg GRAPHIC 105728
21 exh991_19.jpg GRAPHIC 61743
  Complete submission text file 0001171843-15-000100.txt   2806564
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21214 | Film No.: 15509540
SIC: 2834 Pharmaceutical Preparations